A literature search was conducted to evaluate the pharmacokinetic and pharmacodynamic profile of the respiratory fluoroquinolones (gemifloxacin, levofloxacin and moxifloxacin) and their efficacy ...

A number of trials have been conducted with each of the three main antipneumococcal respiratory fluoroquinolones. In an open-label, noncomparative study, gemifloxacin (320 mg, once daily for 7 ...

What is the best career fit for me? Take our assessment now. Finding your dream job starts with knowing what makes you the way you are. Simple Statements that relate to you. Unique Be yourself ...

Cases of flu, COVID and RSV remain high across the U.S., CDC data shows. Respiratory viruses are continuing to spread across the United States, sickening millions of Americans. Overall respiratory ...

Respiratory tract diseases are illnesses that affect components of the respiratory system, including the nasal passages, the bronchi and the lungs. They range from acute infections, such as ...

Associations of pulmonary microvascular blood volume with per cent emphysema and CT emphysema subtypes in the community: the MESA Lung study ...

26, 2024 — What factors lead to chronic respiratory disease ... cancer and shown that these allow immunotherapies to target non-responsive ... A New Ventilator-on-a-Chip Model to Study Lung ...

The pleura is a two-layered membrane that covers the lung. Between the layers is a small amount of lubricating fluid, known as pleural fluid, which helps cushion the lung and reduce friction between ...